NCT02888249

Brief Summary

The purpose of this study is to determine whether the abuse liability of cigarettes with altered composition (cigarettes differing in composition; e.g., tar levels, amount of sugar, casings) is reduced relative to standard composition cigarettes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 2, 2016

Completed
12 months until next milestone

Study Start

First participant enrolled

August 25, 2017

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2021

Completed
Last Updated

October 18, 2022

Status Verified

January 1, 2021

Enrollment Period

4.2 years

First QC Date

August 23, 2016

Last Update Submit

October 17, 2022

Conditions

Keywords

Tobacco withdrawalAutonomic Agents

Outcome Measures

Primary Outcomes (1)

  • Demand Intensity: Number of cigarette puffs obtained at the lowest fixed ratio value

    The primary behavioral economic demand curve metric (demand intensity, i.e., number of cigarette puffs obtained at the lowest fixed ratio value assessed) derived from cigarette consumption in the laboratory

    3 weeks after initiation of home exposure period

Study Arms (4)

Cigarette W

EXPERIMENTAL

Altered composition cigarettes moisture = 12.20 %, tar = 10.40 mg/cigarette, total particulate matter = 12.0 mg/cigarette, high sugar content

Other: Altered composition cigarette

Cigarette X

EXPERIMENTAL

Altered composition cigarettes moisture = 12.10 %, tar = 8.60 mg/cigarette, total particulate matter = 9.60 mg/cigarette, low sugar content

Other: Altered composition cigarette

Cigarette Y

EXPERIMENTAL

Altered composition cigarettes moisture = 13.20 %, tar = 9.10 mg/cigarette, total particulate matter = 10.10 mg/cigarette, low sugar content

Other: Altered composition cigarette

Cigarette Z

EXPERIMENTAL

Altered composition cigarettes moisture = 13.60 %, tar = 8.10 mg/cigarette, total particulate matter = 9.10 mg/cigarette, low sugar content

Other: Altered composition cigarette

Interventions

This double-blind study will systematically determine the abuse liability of altered composition cigarettes using a behavioral economics abuse-liability approach. Altered composition cigarettes (e.g., cigarettes differing in casings, sugars, tar levels, moisture) may result in decreased intake and decreased dependence, although critical questions remain regarding the abuse-liability of altered composition cigarettes, whether exposure to these cigarettes reduces use, and whether altered composition cigarettes will substitute for standard cigarettes. The addictive effects and abuse liability of altered composition cigarettes, therefore, are not well understood, and will be tested in this study.

Cigarette WCigarette XCigarette YCigarette Z

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Smoke at least five cigarettes per day
  • Have an expired carbon monoxide level of more than 8 ppm or a urinary cotinine level of more than 100 ng per milliliter
  • Have a Fagerström Test for Nicotine Dependence score of at least 5 upon screening

You may not qualify if:

  • The intention to quit smoking in the next 30 days
  • The use of other tobacco products in addition to machine-manufactured cigarettes on more than 9 of the previous 30 days
  • Use of "roll your own" cigarettes as an exclusive form of smoking
  • A serious medical or psychiatric disorder or unstable condition
  • Any positive toxicological screening for illicit drugs other than cannabis will be excluded
  • Women who are pregnant, plan to become pregnant or are breast-feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University School of Medicine, Bayview Campus

Baltimore, Maryland, 21224, United States

Location

MeSH Terms

Conditions

Tobacco Use DisorderSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Matthew W Johnson, Ph.D.

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2016

First Posted

September 2, 2016

Study Start

August 25, 2017

Primary Completion

November 10, 2021

Study Completion

November 10, 2021

Last Updated

October 18, 2022

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations